Logo Logo
Hilfe
Hilfe
Switch Language to English

Veit, Tobias; Pan, Ming; Munker, Dieter; Arnold, Paola; Dick, Andrea; Kunze, Susanne; Meiser, Bruno; Schneider, Christian; Michel, Sebastian; Zoller, Michael; Böhm, Stephan; Walter, Julia; Behr, Jürgen; Kneidinger, Nikolaus und Kauke, Teresa (2021): Association of CMV-specific T-cell immunity and risk of CMV infection in lung transplant recipients. In: Clinical Transplantation, Bd. 35, Nr. 6, e14294

Volltext auf 'Open Access LMU' nicht verfügbar.

Abstract

Background Protecting against CMV infection and maintaining CMV in latent state are largely provided by CMV-specific T-cells in lung transplant recipients. The aim of the study was to assess whether a specific T-cell response is associated with the risk for CMV infection in seronegative patients who are at high risk for delayed CMV infection. Methods All CMV-seronegative recipients (R-) from CMV-seropositive donors (D+) between January 2018 and April 2019 were included and retrospectively screened for CMV infection before and after assessment of CMV-specific cell-mediated immunity. Results Thirty-one of the 50 patients (62%) developed early-onset CMV infection. Lower absolute neutrophil counts were significantly associated with early-onset CMV infection. Antiviral prophylaxis was ceased after 137.2 +/- 42.8 days. CMV-CMI were measured at a median of 5.5 months after LTx. 19 patients experienced early and late-onset CMV infection after prophylaxis withdrawal within 15 months post transplantation. Positive CMV-CMI was significantly associated with lower risk of late-onset CMV infection after transplantation in logistic and cox-regression analysis (OR=0.05, p = .01;OR=2,369, p = .026). Conclusion D+/R- lung transplant recipients are at high risk of developing early and late-onset CMV infection. Measurement of CMV-CMI soon after transplantation might further define the CMV infection prediction risk in LTx recipients being at high risk for CMV viremia.

Dokument bearbeiten Dokument bearbeiten